Cue Biopharma (CUE) Other Non Operating Income (2018 - 2020)
Cue Biopharma (CUE) posted Other Non Operating Income of -$23000.0 for Q3 2020, up 11.54% sequentially from -$26000.0 in Q1 2020, and down 560.0% YoY from $5000.0 in Q4 2019.
Cue Biopharma (CUE) Other Non Operating Income (2018 - 2020) Analysis & Trends
Cue Biopharma has reported Other Non Operating Income for 3 years, with the latest figure at -$23000.0 in Q3 2020.
- Quarterly Other Non Operating Income fell 560.0% year-over-year to -$23000.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was -$56922.0 (down 139.71% YoY) and the FY2019 annual result came in at $64078.0, down 61.24% from the prior year.
- Other Non Operating Income rose to -$23000.0 in Q3 2020 per CUE's latest filing, from -$26000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $98000.0 in Q3 2018 and troughed at -$26000.0 in Q1 2020.
- A 3-year average of $18041.5 and a median of $3500.0 in 2018 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2019 and 2020: Other Non Operating Income surged 4700.0% in 2019, then plunged 560.0% in 2020.
- Over 3 years, Other Non Operating Income stood at $66337.0 in 2018, then plunged by 119.48% to -$12922.0 in 2019, then plunged by 77.99% to -$23000.0 in 2020.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$23000.0, -$26000.0, and -$12922.0 for Q3 2020, Q1 2020, and Q4 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cue Biopharma | 152.56 Mn | 135.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -23,000.00 |
| Mar 31, 2020 | -26,000.00 |
| Dec 31, 2019 | -12,922.00 |
| Sep 30, 2019 | 5,000.00 |
| Jun 30, 2019 | 26,000.00 |
| Mar 31, 2019 | 46,000.00 |
| Dec 31, 2018 | 66,337.00 |
| Sep 30, 2018 | 98,000.00 |
| Jun 30, 2018 | 2,000.00 |
| Mar 31, 2018 | -1,000.00 |